Viveros-Carreño D. 29/11/2022

Objective
To assess the rate of pathological response rate, and the oncological outcomes of preoperative brachytherapy (PBT) in early-stage cervical cancer.                                

Conclusion
Preoperative brachytherapy in patients with early-stage cervical cancer could improve pathologic and oncologic outcomes, but it should be assessed in high-quality randomized controlled trials before its implementation in clinical practice.

López Rivera JJ, Zapata Arizabaleta M, Carrillo YD, Gualdron López O.  01/09/2021

Objective
Prenatal cytogenetic evaluation is a key tool for identifying alterations in pregnant women with high risk for fetal chromosomal abnormalities (CA). In Colombia, there are not large-scale reports about the prevalence and pattern of CA in prenatal cytogenetic analysis.

Conclusion
In Colombia, the invasive prenatal cytogenetic analysis continues being an important diagnostic tool available for pregnant women with high risk for fetal CA.

Viveros-Carreño D. 13/07/2022

Objective The objective of this systematic review was to assess the incidence of lymph node metastasis in patients with clinically presumed early-stage low-grade serous ovarian cancer that underwent primary surgical treatment.

Conclusion In patients with early-stage low-grade serous ovarian cancer, lymph node assessment should be discussed when counseling for primary surgical staging.

Read full article

Valencia CM, Vargas-Rodríguez J, Bernal Y. 06/07/2022

Abstract
Objective
We sought to determine if soluble levels of C5b-9, the terminal complement complex, correlate with end-organ injury in preeclampsia.

Conclusion
We identified a pattern of increased urine and low plasma C5b-9 levels in patients with preeclampsia and end-organ injury. Soluble C5b-9 levels may be used to identify complement-mediated end-organ injury in preeclampsia.

Álvarez-Moreno C, Valderrama-Beltrán S.; Rodriguez-Morales A. 20/3/2021

Cortes-JA, Leal AL, Muñetón-López G, Bravo-Ojeda JS, Nocua-Báez LC, Avila V, Alvarez_Moreno C et al. 17/2/2021

Trujillo-Cáceres, S.J., Castillo, J., Alvarez-Moreno, C., Valbuena, A., Acuña, L. 03/01/2021

Delgado-Murcia G, Alvarez-Moreno C, 9/11/2020

Oñate, J., Gutiérrez, C.J.P., Esparza, G., ...Alvarez-Moreno C, Ordonez, K., Villegas, M.et al, 30/7/2022

Garnica-Velandia S, Aristizábal-Ruiz LA, Alvarez-Moreno CA. 11/1/2021

Abstract
Background: To determine the therapeutic effect and tolerability of meropenem in routine clinical practice, in terms of clinical and microbiological response. Methods: A real-world, observational, descriptive, longitudinal study with daily monitoring of clinical history records was conducted on all patients who were medically prescribed meropenem during a period between October 2015 and March 2016 at a university hospital in Bucaramanga (Colombia).